These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 24337828)
1. Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients. Tamaki N; Kurosaki M; Matsuda S; Muraoka M; Yasui Y; Suzuki S; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Takahashi Y; Asahina Y; Izumi N J Gastroenterol; 2014 Nov; 49(11):1495-503. PubMed ID: 24337828 [TBL] [Abstract][Full Text] [Related]
2. Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. Li X; Xu H; Gao P Med Sci Monit; 2019 Sep; 25():7243-7250. PubMed ID: 31558693 [TBL] [Abstract][Full Text] [Related]
3. Noninvasive estimation of fibrosis progression overtime using the FIB-4 index in chronic hepatitis C. Tamaki N; Kurosaki M; Tanaka K; Suzuki Y; Hoshioka Y; Kato T; Yasui Y; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Izumi N J Viral Hepat; 2013 Jan; 20(1):72-6. PubMed ID: 23231087 [TBL] [Abstract][Full Text] [Related]
4. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia. Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248 [TBL] [Abstract][Full Text] [Related]
5. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Demir M; Grünewald F; Lang S; Schramm C; Bowe A; Mück V; Kütting F; Goeser T; Steffen HM Medicine (Baltimore); 2016 Sep; 95(38):e4602. PubMed ID: 27661015 [TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Zhu YF; Tan YF; Xu X; Zheng JL; Zhang BH; Tang HR; Yang JY Medicine (Baltimore); 2019 Dec; 98(50):e18319. PubMed ID: 31852119 [TBL] [Abstract][Full Text] [Related]
7. Computer-aided assessment of hepatic contour abnormalities as an imaging biomarker for the prediction of hepatocellular carcinoma development in patients with chronic hepatitis C. Goshima S; Kanematsu M; Kondo H; Watanabe H; Noda Y; Fujita H; Bae KT Eur J Radiol; 2015 May; 84(5):811-5. PubMed ID: 25650331 [TBL] [Abstract][Full Text] [Related]
8. A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis. Alonso López S; Manzano ML; Gea F; Gutiérrez ML; Ahumada AM; Devesa MJ; Olveira A; Polo BA; Márquez L; Fernández I; Cobo JCR; Rayón L; Riado D; Izquierdo S; Usón C; Real Y; Rincón D; Fernández-Rodríguez CM; Bañares R Hepatology; 2020 Dec; 72(6):1924-1934. PubMed ID: 33022803 [TBL] [Abstract][Full Text] [Related]
9. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic. Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655 [TBL] [Abstract][Full Text] [Related]
10. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study. Papastergiou V; Stampori M; Lisgos P; Pselas C; Prodromidou K; Karatapanis S Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):798-805. PubMed ID: 23395996 [TBL] [Abstract][Full Text] [Related]
11. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin. Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084 [TBL] [Abstract][Full Text] [Related]
12. Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C. Amorim TG; Staub GJ; Lazzarotto C; Silva AP; Manes J; Ferronato Mda G; Shiozawa MB; Narciso-Schiavon JL; Dantas-Correa EB; Schiavon Lde L Ann Hepatol; 2012; 11(6):855-61. PubMed ID: 23109448 [TBL] [Abstract][Full Text] [Related]
13. A laboratory marker, FIB-4 index, as a predictor for long-term outcomes of hepatocellular carcinoma patients after curative hepatic resection. Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A Surgery; 2015 Apr; 157(4):699-707. PubMed ID: 25704421 [TBL] [Abstract][Full Text] [Related]
14. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B. Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861 [TBL] [Abstract][Full Text] [Related]
15. Role of simple biomarkers in predicting fibrosis progression in HCV infection. Mummadi RR; Petersen JR; Xiao SY; Snyder N World J Gastroenterol; 2010 Dec; 16(45):5710-5. PubMed ID: 21128320 [TBL] [Abstract][Full Text] [Related]
16. FIB-4 index for assessing the prognosis of hepatocellular carcinoma in patients with Child-Pugh class A liver function. Ito T; Kumada T; Toyoda H; Tada T J Cancer Res Clin Oncol; 2015 Jul; 141(7):1311-9. PubMed ID: 25648362 [TBL] [Abstract][Full Text] [Related]
17. Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels. Ito T; Kumada T; Toyoda H; Tada T; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S J Viral Hepat; 2015 Oct; 22(10):777-83. PubMed ID: 25608086 [TBL] [Abstract][Full Text] [Related]
18. FIB-4 index is associated with hepatocellular carcinoma risk in HIV-infected patients. Park LS; Tate JP; Justice AC; Lo Re V; Lim JK; Bräu N; Brown ST; Butt AA; Gibert C; Goetz MB; Rimland D; Rodriguez-Barradas MC; Dubrow R Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2512-7. PubMed ID: 22028407 [TBL] [Abstract][Full Text] [Related]
19. Simple non-invasive markers as a predictor of fibrosis and viral response in chronic hepatitis C patients. Arabul M; Aslan F; Alper E; Akpinar Z; Çelık M; Kandemır A; Vatansever S; Ünsal B Turk J Gastroenterol; 2012; 23(5):538-45. PubMed ID: 23161299 [TBL] [Abstract][Full Text] [Related]
20. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]